Biocon Biologics: Arrangements for new loan to repay old debt, possibility of IPO under consideration.

0 0
Read Time:15 Second

Biocon Biologics debt: Biocon subsidiary Biocon Biologics on Thursday said it has raised fresh debt to repay $1.1 billion (Rs 9,300 crore) long-term debt through US dollar bonds and a new syndicated facility. In this, 80 (…) payable by the year 2029 at a coupon of 6.67 percent.

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %

You May Also Like

More From Author

Average Rating

5 Star
0%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%

Leave a Reply

Your email address will not be published. Required fields are marked *